Retinal degenerative diseases continue to cause progressive
vision loss, affecting millions of patients worldwide.
Current treatments may slow disease progression,
but they cannot restore damaged retinal cells.
Retinal degenerative diseases continue to cause progressive vision loss, affecting millions of patients worldwide.
Current treatments may slow disease progression, but they cannot restore damaged retinal cells.
Retinal diseases affect millions
of people worldwide.
Current treatments have limitations
in restoring damaged retinal cells.
Retinal regeneration
offers new hope.
Retinal diseases affect millions
of people worldwide.
Current treatments have limitations
in restoring damaged retinal cells.
Retinal regeneration
Offers new hope.
Discover how Celliaz leverages PROX1 technology to unlock retinal regeneration
and create new possibilities for patients with retinal diseases.
Discover how Celliaz leverages
PROX1 technology to unlock retinal regeneration and create new possibilities
for patients with retinal diseases.
Watch how Celliaz’s anti-PROX1 technology unlocks the regenerative potential of the retina.
Watch how Celliaz’s anti-PROX1 technology unlocks the regenerative potential of the retina.
Advancing innovative therapies through two complementary strategies.
Neutralizing harmful HPs
that suppress tissue regeneration.
Delivering regenerative HPs
to restore tissue function and repair
Lead Optimization
Preclinical
Target Validation
Target Validation
Advancing innovative therapies through two complementary homeoprotein strategies.
Neutralizing harmful homeoproteins that suppress tissue regeneration.
Delivering regenerative homeoproteins
to restore tissue function and repair
Lead Optimization
Preclinical
Target Validation
Target Validation
Creating a New Therapeutic Paradigm for Degenerative Diseases
Creating a New Paradigm for Retinal Regeneration
CREATING A NEW THERAPEUTIC
PARADIGM FOR DEGENERATIVE DISEASES
Tissue Regeneration
By Homeoprotein Targeting Therapies.
Celliaz Co., Ltd.
205 Jinri Hall, KAIST Munji Campus
193 Munji-ro, Yuseong-gu
Daejeon 34051, Republic of Korea
+82-42-716-4061
info@celliaz.com
Retinal Regeneration
Through Homeoprotein Science
Advancing retinal regeneration
through homeoprotein-based
therapeutics.
Celliaz Co., Ltd.
205 Jinri Hall, KAIST Munji Campus
193 Munji-ro, Yuseong-gu
Daejeon 34051, Republic of Korea
+82-42-716-4061
info@celliaz.com